These findings could offer novel insights into how HK3 regulated the activation of immune cells in the tumor microenvironment to mediate immune evasion, and these findings could provide a new theoretical basis for understanding the metabolic network within the glioma microenvironment and identifying new therapeutic targets. The gene discussed is HK3; the disease is central nervous system cancer.